115 related articles for article (PubMed ID: 38353359)
1. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner.
Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P
Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359
[TBL] [Abstract][Full Text] [Related]
2. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
[TBL] [Abstract][Full Text] [Related]
3. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.
Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801
[TBL] [Abstract][Full Text] [Related]
4. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
[TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine reader HNRNPC-mediated downregulation of circITCH prevents miR-224-3p sequestering and contributes to tumorigenesis in nasopharyngeal carcinoma.
Zhou Q; Song W; Li X; Lin J; Zhu C; Cao L; Li W; Lin S
Environ Toxicol; 2024 May; 39(5):2893-2907. PubMed ID: 38299319
[TBL] [Abstract][Full Text] [Related]
6. The m6A reader HNRNPC predicts adverse prognosis and promotes the progression of colorectal cancer.
Yu YM; Hu Y
Technol Health Care; 2024; 32(3):1445-1453. PubMed ID: 37661903
[TBL] [Abstract][Full Text] [Related]
7. HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells.
Gu Z; Yang Y; Ma Q; Wang H; Zhao S; Qi Y; Li Y
Respir Res; 2022 Dec; 23(1):362. PubMed ID: 36536402
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y
Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973
[TBL] [Abstract][Full Text] [Related]
9. CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.
Zheng Z; Zeng X; Zhu Y; Leng M; Zhang Z; Wang Q; Liu X; Zeng S; Xiao Y; Hu C; Pang S; Wang T; Xu B; Peng P; Li F; Tan W
Mol Cancer; 2024 Jan; 23(1):4. PubMed ID: 38184608
[TBL] [Abstract][Full Text] [Related]
10. N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.
Cai Y; Chen T; Wang M; Deng L; Li C; Fu S; Xie K
Diabetes Res Clin Pract; 2023 Mar; 197():110261. PubMed ID: 36681355
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
14. Identification of genetic variants in m
Ying P; Li Y; Yang N; Wang X; Wang H; He H; Li B; Peng X; Zou D; Zhu Y; Zhong R; Miao X; Tian J; Chang J
Arch Toxicol; 2021 Mar; 95(3):1117-1128. PubMed ID: 33474615
[TBL] [Abstract][Full Text] [Related]
15. HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.
Lian B; Yan S; Li J; Bai Z; Li J
Mol Med; 2023 Aug; 29(1):103. PubMed ID: 37528369
[TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
[TBL] [Abstract][Full Text] [Related]
17. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response.
Wu Y; Zhao W; Liu Y; Tan X; Li X; Zou Q; Xiao Z; Xu H; Wang Y; Yang X
EMBO J; 2018 Dec; 37(23):. PubMed ID: 30158112
[TBL] [Abstract][Full Text] [Related]
18. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA.
Zhou Y; Xue X; Luo J; Li P; Xiao Z; Zhang W; Zhou J; Li P; Zhao J; Ge H; Tian Z; Zhao X
Cancer Sci; 2023 Sep; 114(9):3608-3622. PubMed ID: 37417427
[TBL] [Abstract][Full Text] [Related]
20. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]